Bioscience Health Innovations (BHIC) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


BioScience Health Innovations, Inc.  (OTC: BHIC)

Bioscience Health Innovations Profitability Comparisons

Select each Category to receive further Information




BHIC Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 63.63 % 40.3 % 57.31 % 38.76 %
Gross Margin (Q2 TTM) 53.77 % 43.43 % 56.78 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 30.73 % 46.02 % 26.65 %
EBITDA Margin (Q2 MRQ) 0 % 19.08 % 41.07 % 22.17 %
EBITDA Margin (Q2 TTM) 0 % 17.42 % 36.73 % 20.86 %
EBITDA Margin 5 Yr. Avg. - 16.51 % 23.45 % 11.8 %
Operating Margin (Q2 MRQ) -21.02 % 16.43 % 28.71 % 16.03 %
Operating Margin (Q2 TTM) -13.65 % 15.37 % 27.15 % 16.33 %
Operating Margin 5 Yr. Avg. - 9 % 15.67 % 8.21 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 14.13 % 33.67 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) 0 % 10.61 % 29.18 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.6 % 16.35 % 8.29 %
Net Margin (Q2 MRQ) -17.92 % 11.46 % 29.04 % 11.41 %
Net Margin (Q2 TTM) -14.65 % 7.85 % 24.33 % 10.76 %
Net Margin 5 Yr. Avg. - 7.04 % 13.75 % 6.33 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) -52.29 % 7.69 % 14.83 % 9.53 %
Free Cash Flow Margin (Q2 TTM) -34.18 % 16.67 % 21.12 % 9.36 %
Free Cash Flow Margin 5 Yr. Avg. - 14.42 % 18.55 % 9.05 %
Net Cash Flow Margin (Q2 MRQ) 0 % 36.71 % 10.79 % 2.36 %
Net Cash Flow Margin (Q2 TTM) 0 % 2.78 % 2.24 % 1.8 %
Net Cash Flow Margin 5 Yr. Avg. - 2.76 % 0.89 % 1.41 %
Effective Tax Rate (Q2 MRQ) - 15.47 % 13.75 % 18.84 %
Effective Tax Rate (Q2 TTM)